Webinar on Advanced Drug Discovery and Drug Delivery August 26-26, 2020 London, UK

Alexander O. Terent’ev was born in Moscow, in 1973. He received his M.S. in Chemistry of Biologically Active Compounds from D. Mendeleev University of Chemical Technology of Russia, Moscow. PhD degree (2000) and D.Sc. degree (2009) in Organic Chemistry in N.D. Zelinsky Institute of Organic Chemistry RAS. 2011 – Professor D. Mendeleev University of Chemical Technology of Russia. 2016 – Professor RAS. Head of laboratory in N.D. Zelinsky Institute of Organic Chemistry RAS, Head of laboratory in All-Russian Research Institute of Phytopathology. fe He published 3 chapters in books, 100 research papers, and 25 patents.

Organic chemistry

Associate professor of organic chemistry, Faculty of Specific Education, Ain Shams University.

Organic Chemistry

Divya Chadha Manek is the Head of Business Development (Commercial) for the NIHR Clinical Research Network (CRN). Divya’s role is to maintain strategic relationships with Global and UK life sciences companies. Divya facilitates key discussions between life sciences industry and the Clinical Research Network. Divya provides advice and works collaboratively with companies on how they are able to tap into the Clinical Research Network services to ensure clinical studies are set up quickly and effi ciently so that they recruit to time and target. Divya also leads on ensuring that the Clinical Research Network is abreast of new study delivery innovations to ensure that the organization is evolving to service life sciences industry requirements

Pharmaceuticals, Biologics, Biosimilars, Clinical Psychology, Clinical Research, Dementia Care

Tucker has advised major biotechnology firms on a broad range of sales and marketing strategy issues related to the biotech industry, with an emphasis on Oncology and Biosimilars. His experience has focused on global quantitative and qualitative primary market research and forecasting. Tucker was one of the founding members of ZS’s Biosimilars Vertical, and he has led over 30 training sessions across North America and Asia on this topic. Tucker holds an M.B.A. with honors from UCLA, and a B.A. with honors in from Stanford University

Biosimilars, Biologics, Oncology

have diverse leadership experience as a health services professional with significant accomplishments in all aspects of pharmacovigilance, clinical development, medical affairs, regulatory affairs, primary health care, project management & international health programs. I have vast experience of working in diverse therapeutic areas including rare diseases, novel preventive & therapeutic vaccines, monoclonal antibodies, cardiovascular, oncology, neurology, nosocomial diseases, generic and OTC medicines. I am currently working as Disease Area Cluster Lead for Biosimilars & Drug Delivery Devices at Pfizer. Currently Pfizer has the largest biosimilars portfolio in the industry that includes projects on Inflammation, Oncology, Hematology, ophthalmology etc. My past experience includes working as Associate vice president PV and Therapeutic Area Head (Rare Diseases) for Sanofi Genzyme, working as Senior Director & Director for vaccines PV at Sanofi Pasteur, working as Medical Consultant for Apotex Inc Canada. Prior to joining industry I had worked as Joint Executive Director for Pakistan Institute of Medical Sciences (PIMS), Registrar of the Post graduate medical institute PIMS and as Deputy Director General, Ministry of Health Pakistan. I have also worked on various primary healthcare, public health, health planning & development programs as well World food, UNICEF, WHO & JICA assisted programs on drug safety, emergency

Pharmacovigilance, Drug safety.

George Perry (born April 12, 1953 in Lompoc, California) is a neuroscientist recognized in the field of Alzheimer's disease research particularly for his work in oxidative stress. Dr. Perry has studied at many universities and holds multiple degrees including a Bachelor of Arts degree in Zoology from the University of California Santa Barbara and a PhD in Marine Biology from the University of California at San Diego. He is distinguished as one of the top Alzheimer’s disease researcherswith over 1000 publications, more than 60,000 citations, one of the top 100 most-cited scientists in Neuroscience & Behavior and one of the top 25 scientists in free radical research. Dr. Perry is a Semmes Foundation Distinguished chair in Neurobiology and is an active participant in many other scientific associations. In addition, Perry is an Editor of numerous scientific journals including Journal of Alzheimer’s Diseasewhich he founded in 1998. Today, Perry continues his love for research while working as Dean of the College of Sciences at The University of Texas at San Antonio.

role of redox active metals in mediating prooxidant and antioxidant properties